Screener
NewAmsterdam Pharma Company NAMS Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's return on invested capital?
- NewAmsterdam Pharma Company (NAMS) reported return on invested capital of -115.7% in Q2 2026.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about NewAmsterdam Pharma Company's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude